Production of a dendritic cell-based vaccine containing inactivated autologous virus for therapy of patients with chronic human immunodeficiency virus type 1 infection.
Clin. Vaccine Immunol., Feb;16(2):233-40 (2009)
Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals.
Clin. Vaccine Immunol., Feb;15(2):284-92 (2008)
Treating HIV-1 infection with dendritic cells.
Curr. Opin. Mol. Ther., Aug;9(4):353-63 (2007)
CD27 and CD57 expression reveals atypical differentiation of human immunodeficiency virus type 1-specific memory CD8+ T cells.
Clin. Vaccine Immunol., Jan;14(1):74-80 (2007)
In vitro and in vivo protein sampling by combined microdialysis and ultrafiltration.
J. Immunol. Methods., Feb;309(1-2):55-68 (2006)
Proinflammatory cytokines in HIV disease-a review and rationale for new therapeutic approaches.
AIDS Rev., 7(3):168-80 (2005 Jul-Sep)